HEMO-GE.ApS: Financial statements 2020
CVR: 39076322
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,950 and a net result of DKK 96,002 compared with DKK -4,580 the year before. Equity in the 2020 report amounted to DKK 2,057,990. The solvency ratio was 99.8%.
- Gross Profit
- DKK -3,950
- Profit/Loss
- DKK 96,002
- Equity
- DKK 2,057,990
- Total Assets
- DKK 2,061,840
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -4 t. | 96 t. | 2.1 mio. | - |
| 2019 | - | -4 t. | -5 t. | 2.1 mio. | - |
| 2018 | - | -7 t. | 194 t. | 2.2 mio. | - |
Official annual report
How creditworthy is HEMO-GE.ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.